MACURE PHARMA ApS — Credit Rating and Financial Key Figures

MACURE PHARMA ApS (CVR number: 35234748) is a company from KØBENHAVN. The company recorded a gross profit of 24.2 mDKK in 2023. The operating profit was 11.6 mDKK, while net earnings were 8790.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was 10.3 %, which can be considered good but Return on Equity (ROE) was 46.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 8.3 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. MACURE PHARMA ApS's liquidity measured by quick ratio was 0.9 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.